• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清抗环瓜氨酸肽抗体可预测类风湿关节炎的疾病活动度。

Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis.

机构信息

Internal Medicine Ward, Division of Rheumatology, Shahid Beheshti Hospital, Kashan University of Medical Sciences, Kashan, Iran.

出版信息

Rheumatol Int. 2012 Dec;32(12):3799-805. doi: 10.1007/s00296-011-2282-3. Epub 2011 Dec 21.

DOI:10.1007/s00296-011-2282-3
PMID:22187060
Abstract

To define the relationship between serum anti-cyclic citrullinated peptide antibodies (anti-CCP) and disease activity, and to construct a new disease activity index by using anti-CCP in rheumatoid arthritis (RA). One hundred and five RA patients were included. Disease activity based on DAS28-ESR and serum anti-CCP was measured. There was correlation between serum anti-CCP and DAS28-ESR. (R (2) = 0.71, P value < 0.01). New disease activity index was developed by replacing anti-CCP with ESR in DAS28-ESR. There was correlation between new model and DAS28-ESR. (R (2) = 0.91, P value < 0.01) The new composite index best cut-off values corresponding to DAS28-ESR values of 2.6, 3.2, and 5.1 were 3.21, 3.38, and 4.74, respectively. There was agreement between new model and DAS28-ESR for determination of patients in different disease activity categories. (Kappa = 0.71, P value < 0.01). The new disease activity index that applies serum anti-CCP may predict disease activity in RA.

摘要

为了明确血清抗环瓜氨酸肽抗体(抗-CCP)与疾病活动度之间的关系,并在类风湿关节炎(RA)中构建一个新的疾病活动指数,纳入了 105 例 RA 患者。根据 DAS28-ESR 和血清抗-CCP 评估疾病活动度。血清抗-CCP 与 DAS28-ESR 之间存在相关性(R(2)= 0.71,P 值<0.01)。通过用 ESR 替代 DAS28-ESR 中的抗-CCP 来建立新的疾病活动指数。新模型与 DAS28-ESR 之间存在相关性(R(2)= 0.91,P 值<0.01)。与 DAS28-ESR 值为 2.6、3.2 和 5.1 相对应的新综合指数最佳截断值分别为 3.21、3.38 和 4.74。新模型与 DAS28-ESR 在确定不同疾病活动度类别的患者方面具有一致性(Kappa = 0.71,P 值<0.01)。应用血清抗-CCP 的新疾病活动指数可能有助于预测 RA 的疾病活动度。

相似文献

1
Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis.血清抗环瓜氨酸肽抗体可预测类风湿关节炎的疾病活动度。
Rheumatol Int. 2012 Dec;32(12):3799-805. doi: 10.1007/s00296-011-2282-3. Epub 2011 Dec 21.
2
Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity.抗环瓜氨酸肽抗体而非类风湿因子与至少中度疾病活动的类风湿关节炎患者的超声检测到的骨侵蚀相关。
Int J Rheum Dis. 2020 Oct;23(10):1337-1343. doi: 10.1111/1756-185X.13933. Epub 2020 Aug 17.
3
The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.抗环瓜氨酸肽抗体、基质金属蛋白酶-3、类风湿因子、红细胞沉降率及C反应蛋白在侵蚀性和非侵蚀性类风湿关节炎患者中的诊断效用
Clin Dev Immunol. 2005 Sep;12(3):197-202. doi: 10.1080/17402520500233510.
4
Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.相比于抗环瓜氨酸肽抗体,抗突变型瓜氨酸波形蛋白抗体在预测早期类风湿关节炎24个月时的疾病活动方面表现更佳。
J Rheumatol. 2008 Jun;35(6):1002-8. Epub 2008 Apr 1.
5
Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.类风湿关节炎中靶向肽基精氨酸脱亚氨酶4、突变型瓜氨酸波形蛋白和环瓜氨酸肽的自身抗体的比较分析:与细胞因子谱、临床和遗传特征的关联
Clin Exp Immunol. 2015 Nov;182(2):119-31. doi: 10.1111/cei.12677. Epub 2015 Sep 16.
6
[The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].抗环瓜氨酸肽(anti-CCP)抗体在类风湿关节炎血清学诊断及疾病活动度评估中的作用
Mikrobiyol Bul. 2008 Oct;42(4):669-74.
7
Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.抗环瓜氨酸肽抗体和抗瓜氨酸化波形蛋白抗体在类风湿关节炎中的诊断效用
Protein Pept Lett. 2008;15(3):314-7. doi: 10.2174/092986608783744153.
8
The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.抗环瓜氨酸肽抗体与类风湿关节炎疾病活动度的关联。
Rheumatol Int. 2008 Aug;28(10):965-70. doi: 10.1007/s00296-008-0570-3. Epub 2008 Apr 17.
9
Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.抗环瓜氨酸肽和类风湿因子在类风湿关节炎患者中的诊断效能
Int J Rheum Dis. 2016 Sep;19(9):880-6. doi: 10.1111/1756-185X.12552. Epub 2015 May 4.
10
Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.抗环瓜氨酸肽抗体与类风湿关节炎患者的类风湿因子及放射学缺损高度相关。
Medicine (Baltimore). 2019 Mar;98(12):e14945. doi: 10.1097/MD.0000000000014945.

引用本文的文献

1
Serum Tumor Necrosis Factor-Alpha as a Competent Biomarker for Evaluation of Disease Activity in Early Rheumatoid Arthritis.血清肿瘤坏死因子-α作为评估早期类风湿关节炎疾病活动度的有效生物标志物。
Cureus. 2021 May 29;13(5):e15314. doi: 10.7759/cureus.15314.
2
Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.抗瓜氨酸化肽抗体及其预测生物制剂反应的价值:综述
Rheumatol Int. 2016 Aug;36(8):1043-63. doi: 10.1007/s00296-016-3506-3. Epub 2016 Jun 6.

本文引用的文献

1
Serum adenosine deaminase may predict disease activity in rheumatoid arthritis.血清腺苷脱氨酶可能预测类风湿关节炎的疾病活动度。
Rheumatol Int. 2012 Jul;32(7):1967-75. doi: 10.1007/s00296-011-1912-0. Epub 2011 Apr 3.
2
Increased myeloperoxidase plasma levels in rheumatoid arthritis.类风湿关节炎患者血浆髓过氧化物酶水平升高。
Rheumatol Int. 2012 Jun;32(6):1605-9. doi: 10.1007/s00296-011-1810-5. Epub 2011 Feb 18.
3
Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan.
抗环瓜氨酸肽抗体可预测日本大型前瞻性观察队列中类风湿关节炎患者的功能残疾。
Rheumatol Int. 2012 Feb;32(2):361-6. doi: 10.1007/s00296-010-1671-3. Epub 2010 Nov 27.
4
Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.接受甲氨蝶呤治疗的类风湿关节炎患者影像学进展的相关因素。
J Rheumatol. 2011 Feb;38(2):242-6. doi: 10.3899/jrheum.091446. Epub 2010 Nov 15.
5
Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study.类风湿关节炎放射学损伤的预后因素:一项 10 年回顾性研究。
J Rheumatol. 2011 Jan;38(1):44-52. doi: 10.3899/jrheum.100514. Epub 2010 Oct 15.
6
The continuous measurement of anti-CCP-antibodies does not help to evaluate the disease activity in anti-CCP-antibody-positive patients with rheumatoid arthritis.抗 CCP 抗体的连续测量无助于评估抗 CCP 抗体阳性类风湿关节炎患者的疾病活动度。
Clin Rheumatol. 2010 Dec;29(12):1449-53. doi: 10.1007/s10067-010-1557-5. Epub 2010 Sep 14.
7
Synovial fluid adenosine deaminase and high-sensitivity C-reactive protein activity in differentiating monoarthritis.滑液中的腺苷脱氨酶和高敏 C 反应蛋白活性在鉴别单关节炎中的作用。
Rheumatol Int. 2012 Jan;32(1):183-8. doi: 10.1007/s00296-010-1602-3. Epub 2010 Aug 19.
8
Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity.类风湿关节炎患者血浆可溶性白细胞介素 6 受体浓度:与 rs8192284IL6R 多态性和疾病活动的相关性。
Rheumatol Int. 2011 Mar;31(3):409-13. doi: 10.1007/s00296-010-1593-0. Epub 2010 Jul 27.
9
Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study.评估红细胞沉降率(DAS28-ESR)作为托珠单抗治疗 24 周疗效评估中类风湿关节炎疾病活动指数的 28 关节疾病活动评分(DAS28-ESR)的有效性:SATORI 研究的亚分析。
Mod Rheumatol. 2010 Dec;20(6):539-47. doi: 10.1007/s10165-010-0328-0. Epub 2010 Jul 10.
10
Antibodies against cyclic citrullinated peptide don't decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis.对于难治性类风湿关节炎患者,使用英夫利昔单抗治疗 6 个月后,其针对环瓜氨酸肽的抗体并未减少。
Rheumatol Int. 2011 Nov;31(11):1439-43. doi: 10.1007/s00296-010-1509-z. Epub 2010 May 15.